JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

Linus Wahnschaffe(University of Cologne), Marco Herling(TH Köln - University of Applied Sciences)

Cancers

November 21, 2019

10.3390/cancers11121833

Cited by 66

Related Papers

CD4+/CD56+ Hematodermic Tumor

|American Journal of Clinical Pathology|2007|172

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

|Nature Communications|2018|105

Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden

|Molecular Cancer|2015|24

Lilienthal N et al., Immunokinase-based B-lymphotoxic delivery of activated DAPK1; Supplements from A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells

|Unknown|2023|0